Global Leukemia Therapeutic Market Size, Status and Forecast 2021-2027

  • Published Date : 06-09-2021
  • Pages : 96
  • Report Id : 54323
  • Categories : Healthcare

This report focuses on the global Leukemia Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Leukemia Therapeutic development in United States, Europe and China.

Leukemia is a type of cancer which is formed in blood tissues. Leukemia occurs in bone marrow which is a soft tissue. Leukemia develops by the uncontrolled growth of blood cells in the bone marrow. Leukemia is also defined as a cancer of white blood cells. Leukemia therapeutics consists of three steps including induction therapy, consolidation therapy and maintenance therapy.
In recent time there is increased use of leukemia therapeutic due to rising number of cancer diseases across the world. Rising aging population, lifestyle factors and increasing awareness for healthcare are some of the key driving factors for the growth of the global leukemia therapeutics market. In addition, innovative and targeted drug delivery is also fuelling the growth of the global leukemia therapeutics market. However, availability of large numbers of generic form of drugs and limited treatment options are some of the major factors restraining the growth of the global leukemia therapeutics market. In addition, high unmet need for diagnosis is also restraining the growth of the global leukemia therapeutics market.
North America followed by Europe dominates the global leukemia therapeutics market due to rising incidence of cancer and growing aging population. Asia is expected to show high growth rate due to rising incidence of cancer. China and India are expected to be the fastest growing leukemia markets in Asia region. Some of the key driving forces for the leukemia therapeutic market in emerging countries are increasing R&D investment, large pool of patients and rising government funding.
In 2020, the global Leukemia Therapeutic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.

The key players covered in this study
Genzyme
Novartis International
Pfizer
Roche Holding
Celgene Corporation
Ariad Pharmaceuticals
Clavis Pharma
Sunesis Pharmaceuticals

Market segment by Type, the product can be split into
Induction Therapy
Consolidation Therapy
Maintenance Therapy

Market segment by Application, split into
Cancer Research Centers
Diagnostic Laboratories
Clinics
Hospitals

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Leukemia Therapeutic status, future forecast, growth opportunity, key market and key players.
To present the Leukemia Therapeutic development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Leukemia Therapeutic are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
End of Summary


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Leukemia Therapeutic Market Size Growth Rate by Type (2016-2027)
1.4.2 Induction Therapy
1.4.3 Consolidation Therapy
1.4.4 Maintenance Therapy
1.5 Market by Application
1.5.1 Global Leukemia Therapeutic Market Share by Application (2016-2027)
1.5.2 Cancer Research Centers
1.5.3 Diagnostic Laboratories
1.5.4 Clinics
1.5.5 Hospitals
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Leukemia Therapeutic Market Size
2.2 Leukemia Therapeutic Growth Trends by Regions
2.2.1 Leukemia Therapeutic Market Size by Regions (2016-2027)
2.2.2 Leukemia Therapeutic Market Share by Regions (2016-2021)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Leukemia Therapeutic Market Size by Manufacturers
3.1.1 Global Leukemia Therapeutic Revenue by Manufacturers (2016-2021)
3.1.2 Global Leukemia Therapeutic Revenue Market Share by Manufacturers (2016-2021)
3.1.3 Global Leukemia Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2 Leukemia Therapeutic Key Players Head office and Area Served
3.3 Key Players Leukemia Therapeutic Product/Solution/Service
3.4 Date of Enter into Leukemia Therapeutic Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Leukemia Therapeutic Market Size by Type (2016-2021)
4.2 Global Leukemia Therapeutic Market Size by Application (2016-2021)

5 United States
5.1 United States Leukemia Therapeutic Market Size (2016-2021)
5.2 Leukemia Therapeutic Key Players in United States
5.3 United States Leukemia Therapeutic Market Size by Type
5.4 United States Leukemia Therapeutic Market Size by Application

6 Europe
6.1 Europe Leukemia Therapeutic Market Size (2016-2021)
6.2 Leukemia Therapeutic Key Players in Europe
6.3 Europe Leukemia Therapeutic Market Size by Type
6.4 Europe Leukemia Therapeutic Market Size by Application

7 China
7.1 China Leukemia Therapeutic Market Size (2016-2021)
7.2 Leukemia Therapeutic Key Players in China
7.3 China Leukemia Therapeutic Market Size by Type
7.4 China Leukemia Therapeutic Market Size by Application

8 Japan
8.1 Japan Leukemia Therapeutic Market Size (2016-2021)
8.2 Leukemia Therapeutic Key Players in Japan
8.3 Japan Leukemia Therapeutic Market Size by Type
8.4 Japan Leukemia Therapeutic Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Leukemia Therapeutic Market Size (2016-2021)
9.2 Leukemia Therapeutic Key Players in Southeast Asia
9.3 Southeast Asia Leukemia Therapeutic Market Size by Type
9.4 Southeast Asia Leukemia Therapeutic Market Size by Application

10 India
10.1 India Leukemia Therapeutic Market Size (2016-2021)
10.2 Leukemia Therapeutic Key Players in India
10.3 India Leukemia Therapeutic Market Size by Type
10.4 India Leukemia Therapeutic Market Size by Application

11 Central & South America
11.1 Central & South America Leukemia Therapeutic Market Size (2016-2021)
11.2 Leukemia Therapeutic Key Players in Central & South America
11.3 Central & South America Leukemia Therapeutic Market Size by Type
11.4 Central & South America Leukemia Therapeutic Market Size by Application

12 International Players Profiles
12.1 Genzyme
12.1.1 Genzyme Company Details
12.1.2 Company Description and Business Overview
12.1.3 Leukemia Therapeutic Introduction
12.1.4 Genzyme Revenue in Leukemia Therapeutic Business (2016-2021)
12.1.5 Genzyme Recent Development
12.2 Novartis International
12.2.1 Novartis International Company Details
12.2.2 Company Description and Business Overview
12.2.3 Leukemia Therapeutic Introduction
12.2.4 Novartis International Revenue in Leukemia Therapeutic Business (2016-2021)
12.2.5 Novartis International Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Leukemia Therapeutic Introduction
12.3.4 Pfizer Revenue in Leukemia Therapeutic Business (2016-2021)
12.3.5 Pfizer Recent Development
12.4 Roche Holding
12.4.1 Roche Holding Company Details
12.4.2 Company Description and Business Overview
12.4.3 Leukemia Therapeutic Introduction
12.4.4 Roche Holding Revenue in Leukemia Therapeutic Business (2016-2021)
12.4.5 Roche Holding Recent Development
12.5 Celgene Corporation
12.5.1 Celgene Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Leukemia Therapeutic Introduction
12.5.4 Celgene Corporation Revenue in Leukemia Therapeutic Business (2016-2021)
12.5.5 Celgene Corporation Recent Development
12.6 Ariad Pharmaceuticals
12.6.1 Ariad Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Leukemia Therapeutic Introduction
12.6.4 Ariad Pharmaceuticals Revenue in Leukemia Therapeutic Business (2016-2021)
12.6.5 Ariad Pharmaceuticals Recent Development
12.7 Clavis Pharma
12.7.1 Clavis Pharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Leukemia Therapeutic Introduction
12.7.4 Clavis Pharma Revenue in Leukemia Therapeutic Business (2016-2021)
12.7.5 Clavis Pharma Recent Development
12.8 Sunesis Pharmaceuticals
12.8.1 Sunesis Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Leukemia Therapeutic Introduction
12.8.4 Sunesis Pharmaceuticals Revenue in Leukemia Therapeutic Business (2016-2021)
12.8.5 Sunesis Pharmaceuticals Recent Development

13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures

Table Leukemia Therapeutic Key Market Segments
Table Key Players Leukemia Therapeutic Covered
Table Global Leukemia Therapeutic Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Leukemia Therapeutic Market Size Market Share by Type 2016-2027
Figure Induction Therapy Figures
Table Key Players of Induction Therapy
Figure Consolidation Therapy Figures
Table Key Players of Consolidation Therapy
Figure Maintenance Therapy Figures
Table Key Players of Maintenance Therapy
Table Global Leukemia Therapeutic Market Size Growth by Application 2016-2027 (Million US$)
Figure Cancer Research Centers Case Studies
Figure Diagnostic Laboratories Case Studies
Figure Clinics Case Studies
Figure Hospitals Case Studies
Figure Leukemia Therapeutic Report Years Considered
Table Global Leukemia Therapeutic Market Size 2016-2027 (Million US$)
Figure Global Leukemia Therapeutic Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Leukemia Therapeutic Market Size by Regions 2016-2027 (Million US$)
Table Global Leukemia Therapeutic Market Size by Regions 2016-2021 (Million US$)
Table Global Leukemia Therapeutic Market Share by Regions 2016-2021
Figure Global Leukemia Therapeutic Market Share by Regions 2016-2021
Figure Global Leukemia Therapeutic Market Share by Regions 2021
Table Market Top Trends
Table Global Leukemia Therapeutic Revenue by Manufacturers (2016-2021) (Million US$)
Table Global Leukemia Therapeutic Market Share by Manufacturers (2016-2021)
Figure Global Leukemia Therapeutic Market Share by Manufacturers in 2021
Table Global Leukemia Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Leukemia Therapeutic Product/Solution/Service
Table Date of Enter into Leukemia Therapeutic Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Leukemia Therapeutic Market Size by Type (2016-2021) (Million US$)
Table Global Leukemia Therapeutic Market Size Share by Type (2016-2021)
Figure Global Leukemia Therapeutic Market Size Market Share by Type (2016-2021)
Table Global Leukemia Therapeutic Market Size by Application (2016-2021) (Million US$)
Table Global Leukemia Therapeutic Market Size Share by Application (2016-2021)
Figure Global Leukemia Therapeutic Market Size Market Share by Application (2016-2021)
Figure Global Leukemia Therapeutic Revenue Market Share by Application in 2020
Figure United States Leukemia Therapeutic Market Size 2016-2021 (Million US$)
Table United States Key Players Leukemia Therapeutic Revenue (2020-2021) (Million US$)
Table United States Key Players Leukemia Therapeutic Market Share (2020-2021)
Table United States Leukemia Therapeutic Market Size by Type (2016-2021) (Million US$)
Table United States Leukemia Therapeutic Market Share by Type (2016-2021)
Table United States Leukemia Therapeutic Market Size by Application (2016-2021) (Million US$)
Table United States Leukemia Therapeutic Market Share by Application (2016-2021)
Figure Europe Leukemia Therapeutic Market Size 2016-2021 (Million US$)
Table Europe Key Players Leukemia Therapeutic Revenue (2020-2021) (Million US$)
Table Europe Key Players Leukemia Therapeutic Market Share (2020-2021)
Table Europe Leukemia Therapeutic Market Size by Type (2016-2021) (Million US$)
Table Europe Leukemia Therapeutic Market Share by Type (2016-2021)
Table Europe Leukemia Therapeutic Market Size by Application (2016-2021) (Million US$)
Table Europe Leukemia Therapeutic Market Share by Application (2016-2021)
Figure China Leukemia Therapeutic Market Size 2016-2021 (Million US$)
Table China Key Players Leukemia Therapeutic Revenue (2020-2021) (Million US$)
Table China Key Players Leukemia Therapeutic Market Share (2020-2021)
Table China Leukemia Therapeutic Market Size by Type (2016-2021) (Million US$)
Table China Leukemia Therapeutic Market Share by Type (2016-2021)
Table China Leukemia Therapeutic Market Size by Application (2016-2021) (Million US$)
Table China Leukemia Therapeutic Market Share by Application (2016-2021)
Figure Japan Leukemia Therapeutic Market Size 2016-2021 (Million US$)
Table Japan Key Players Leukemia Therapeutic Revenue (2020-2021) (Million US$)
Table Japan Key Players Leukemia Therapeutic Market Share (2020-2021)
Table Japan Leukemia Therapeutic Market Size by Type (2016-2021) (Million US$)
Table Japan Leukemia Therapeutic Market Share by Type (2016-2021)
Table Japan Leukemia Therapeutic Market Size by Application (2016-2021) (Million US$)
Table Japan Leukemia Therapeutic Market Share by Application (2016-2021)
Figure Southeast Asia Leukemia Therapeutic Market Size 2016-2021 (Million US$)
Table Southeast Asia Key Players Leukemia Therapeutic Revenue (2020-2021) (Million US$)
Table Southeast Asia Key Players Leukemia Therapeutic Market Share (2020-2021)
Table Southeast Asia Leukemia Therapeutic Market Size by Type (2016-2021) (Million US$)
Table Southeast Asia Leukemia Therapeutic Market Share by Type (2016-2021)
Table Southeast Asia Leukemia Therapeutic Market Size by Application (2016-2021) (Million US$)
Table Southeast Asia Leukemia Therapeutic Market Share by Application (2016-2021)
Figure India Leukemia Therapeutic Market Size 2016-2021 (Million US$)
Table India Key Players Leukemia Therapeutic Revenue (2020-2021) (Million US$)
Table India Key Players Leukemia Therapeutic Market Share (2020-2021)
Table India Leukemia Therapeutic Market Size by Type (2016-2021) (Million US$)
Table India Leukemia Therapeutic Market Share by Type (2016-2021)
Table India Leukemia Therapeutic Market Size by Application (2016-2021) (Million US$)
Table India Leukemia Therapeutic Market Share by Application (2016-2021)
Figure Central & South America Leukemia Therapeutic Market Size 2016-2021 (Million US$)
Table Central & South America Key Players Leukemia Therapeutic Revenue (2020-2021) (Million US$)
Table Central & South America Key Players Leukemia Therapeutic Market Share (2020-2021)
Table Central & South America Leukemia Therapeutic Market Size by Type (2016-2021) (Million US$)
Table Central & South America Leukemia Therapeutic Market Share by Type (2016-2021)
Table Central & South America Leukemia Therapeutic Market Size by Application (2016-2021) (Million US$)
Table Central & South America Leukemia Therapeutic Market Share by Application (2016-2021)
Table Genzyme Company Details
Table Genzyme Revenue in Leukemia Therapeutic Business (2016-2021) (Million US$)
Figure Genzyme Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Table Genzyme Recent Development
Table Novartis International Company Details
Table Novartis International Revenue in Leukemia Therapeutic Business (2016-2021)(Million US$)
Figure Novartis International Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Table Novartis International Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Leukemia Therapeutic Business (2016-2021)(Million US$)
Figure Pfizer Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Table Pfizer Recent Development
Table Roche Holding Company Details
Table Roche Holding Revenue in Leukemia Therapeutic Business (2016-2021)(Million US$)
Figure Roche Holding Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Table Roche Holding Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Leukemia Therapeutic Business (2016-2021)(Million US$)
Figure Celgene Corporation Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Table Celgene Corporation Recent Development
Table Ariad Pharmaceuticals Company Details
Table Ariad Pharmaceuticals Revenue in Leukemia Therapeutic Business (2016-2021)(Million US$)
Figure Ariad Pharmaceuticals Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Table Ariad Pharmaceuticals Recent Development
Table Clavis Pharma Company Details
Table Clavis Pharma Revenue in Leukemia Therapeutic Business (2016-2021)(Million US$)
Figure Clavis Pharma Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Table Clavis Pharma Recent Development
Table Sunesis Pharmaceuticals Company Details
Table Sunesis Pharmaceuticals Revenue in Leukemia Therapeutic Business (2016-2021)(Million US$)
Figure Sunesis Pharmaceuticals Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Table Sunesis Pharmaceuticals Recent Development
Table Global Leukemia Therapeutic Market Size by Regions (Million US$) 2021-2027
Figure Global Leukemia Therapeutic Market Size Share by Regions (2021-2027)
Figure Global Leukemia Therapeutic Market Size Share by Regions in 2025
Figure United States Leukemia Therapeutic Market Size Forecast (2021-2027)(Million USD)
Figure Europe Leukemia Therapeutic Market Size Forecast (2021-2027)(Million USD)
Figure China Leukemia Therapeutic Market Size Forecast (2021-2027)(Million USD)
Figure Japan Leukemia Therapeutic Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Leukemia Therapeutic Market Size Forecast (2021-2027)(Million USD)
Figure India Leukemia Therapeutic Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Leukemia Therapeutic Market Size Forecast (2021-2027)(Million USD)
Table Global Leukemia Therapeutic Market Size by Product (2021-2027) (Million US$)
Figure Global Leukemia Therapeutic Market Size by Product (2021-2027)
Figure Global Leukemia Therapeutic Market Size by Product in 2025
Table Global Leukemia Therapeutic Market Size by Application (2021-2027) (Million US$)
Figure Global Leukemia Therapeutic Market Size by Application (2021-2027)
Figure Global Leukemia Therapeutic Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Direct Purchase
Your perfect start with Research Allied


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo

You may also be lnterested in..

Research Allied Copyright © 2021 .